Alazne Arzuaga

Influence of Renal Function on the Pharmacokinetics of Piperacillin/Tazobactam in Intensive Care Unit Patients During Continuous Venovenous Hemofiltration

Alazne Arzuaga, Javier Maynar, Alicia Rodríguez‐Gascón et al. · The Journal of Clinical Pharmacology · 2005 · 65 citations

Dialysis Therapy, Pharmacotherapy, Pharmacokinetics +16

Cefepime and continuous renal replacement therapy (CRRT): In vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients

Alicia Rodríguez‐Gascón, Javier Maynar, Alazne Arzuaga et al. · Clinical Therapeutics · 2005 · 63 citations

Vitro Permeability, Ill Patients, Urology +8

Meropenem and Continuous Renal Replacement Therapy: In Vitro Permeability of 2 Continuous Renal Replacement Therapy Membranes and Influence of Patient Renal Function on the Pharmacokinetics in Critically Ill Patients

Javier Maynar, José Ángel Sánchez‐Izquierdo, Alicia Rodríguez‐Gascón et al. · The Journal of Clinical Pharmacology · 2005 · 58 citations

Determination of ceftazidime and cefepime in plasma and dialysate-ultrafiltrate from patients undergoing continuous veno-venous hemodiafiltration by HPLC

Arantxa Isla, Alazne Arzuaga, Javier Maynar et al. · Journal of Pharmaceutical and Biomedical Analysis · 2005 · 39 citations

Venous Disease, Hematology, Continuous Veno-venous Hemodiafiltration +5

In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes

Alicia Rodríguez‐Gascón, Javier Maynar, Alazne Arzuaga et al. · Clinical Therapeutics · 2005 · 31 citations

Urology, Vivo Evaluation, Enoxaparin Removal +4